Safety of live attenuated herpes zoster vaccine in Australian adults 70–79 years of age: an observational study using active surveillance

Safety of live attenuated herpes zoster vaccine in Australian adults 70–79 years of age: an observational study using active surveillance

Objectives To assess the safety of live attenuated herpes zoster vaccine live (ZVL) through cumulative analysis of near real-time, participant-based active surveillance from Australia’s AusVaxSafety system.Design and setting ZVL was funded in Australia for adults aged 70 years from November 2016, wi...

Full description

Bibliographic Details
Main Authors: Parveen Fathima, Thomas L Snelling, Catherine Glover, David Durrheim, Alan Leeb, Anastasia Phillips, Patrick Cashman, Nigel Crawford
Format: Article
Language:English
Published: BMJ Publishing Group 2021-03-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/3/e043880.full

Internet

https://bmjopen.bmj.com/content/11/3/e043880.full

Similar Items